MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$19,248K
Net Income
-$16,565K
Net Profit Margin
-86.06%
EPS
-$0.11
Unit: Thousand (K) dollars
Revenue Breakdown
Product revenues, net
License revenues and royalties
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue, net
19,248
20,851
23,058
16,427
Cost of product sales
2,349
3,615
1,699
1,202
Research and development
17,366
19,877
18,184
26,803
Selling and marketing
12,572
12,708
11,986
10,688
General and administrative
9,701
9,896
9,456
8,326
Restructuring and impairment expenses
2,674
-
-348
377
Total operating expense
44,662
46,096
40,977
47,396
Loss from operations
-25,414
-25,245
-17,919
-30,969
Interest income
1,819
1,994
2,352
2,470
Deferred royalty obligation interest expense
9,125
8,727
9,182
8,996
Effective interest expense on senior secured term loan facility
-
-
3,829*
-
Other interest expense
-
-
3*
-
Effective interest expense on senior secured term loan facility
4,383
3,622
-
4,396
Interest expense
13,508
12,349
13,014
13,392
Other, net
20,538
2,632
21,768
925
Total other income (expense), net
8,849
-7,723
11,106
-9,997
Loss before income taxes
-16,565
-32,968
-6,813
-40,966
Income tax expense
0
0
-404
0
Loss before equity in net losses of joint venture
-
-
-6,409
-40,966
Equity in net losses of joint venture
-
-
0
0
Net loss
-16,565
-32,968
-6,409
-40,966
Basic EPS
-0.11
-0.21
-0.042
-0.3
Diluted EPS
-0.11
-0.21
-0.042
-0.3
Basic Average Shares
155,016,023
154,142,347
150,877,894
136,446,534
Diluted Average Shares
155,016,023
154,142,347
150,877,894
136,446,534
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$16,565K
(70.76%↑ Y/Y)
Other, net
$20,538K
(11384.62%↑ Y/Y)
Interest income
$1,819K
(-5.95%↓ Y/Y)
Loss before income
taxes
-$16,565K
(70.09%↑ Y/Y)
Total other income
(expense), net
$8,849K
(178.69%↑ Y/Y)
Product revenues, net
$18,634K
(3.04%↑ Y/Y)
License revenues and
royalties
$614K
(-18.57%↓ Y/Y)
Interest expense
$13,508K
(3.93%↑ Y/Y)
Loss from operations
-$25,414K
(42.43%↑ Y/Y)
Total revenue, net
$19,248K
(2.17%↑ Y/Y)
Deferred royalty
obligation interest...
$9,125K
(4.61%↑ Y/Y)
Effective interest
expense on senior...
$4,383K
(2.55%↑ Y/Y)
Total operating
expense
$44,662K
(-29.09%↓ Y/Y)
Research and development
$17,366K
(-42.29%↓ Y/Y)
Selling and marketing
$12,572K
(23.90%↑ Y/Y)
General and
administrative
$9,701K
(9.96%↑ Y/Y)
Restructuring and impairment
expenses
$2,674K
(-79.57%↓ Y/Y)
Cost of product sales
$2,349K
(180.98%↑ Y/Y)
Buy us a coffee
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT)